Millennium Management »

Telomir Pharmaceuticals shares owned by Millennium Management

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $309k 222k 1.39
2025-06-30 $310k 248k 1.25

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Telomir Pharmaceuticals

Vanguard Group
BlackRock
Millennium Management
Geode Capital Management
Raymond James Financial
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Northern Trust
Advisor Group Holdings
Resources Investment Advisors
Goldman Sachs Group
Mariner Wealth Advisors
Jane Street
UBS Group

View all funds holding Telomir Pharmaceuticals